Digital Media briefs

Share this article:
Everyday Health commissioned a comScore study that found US consumers online—roughly 191 million on average—visited approximately nine different health sites in six months. While only 60% of consumers in any given month visit health sites, almost everyone online is considered a health viewer when you look at six months, said Carolina Petrini, VP of research at Everyday Health. Over the six months surveyed, consumers visited 9.4 health sites, 182.2 pages, and spent 128 minutes on health content.  
FDA launched a Twitter profile focused specifically on prescription drugs. The agency said it will use the application to provide “timely information on new drug approvals, safety alerts, compliance actions and consumer information.” FDA will not respond to replies or direct messages, the agency said in an online disclaimer.

The Stanford University School of Medicine joined the University of Philadelphia, the Cleveland Clinic and others in a decision to publicly disclose information about the consulting activities of its 1,400 affiliated faculty. As of August, faculty profiles on the school's website will include information about any consulting relationships with specific companies.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?